{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T10:55:18Z","timestamp":1795085718615,"version":"4.10.2"},"reference-count":89,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T00:00:00Z","timestamp":1741737600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T00:00:00Z","timestamp":1741737600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100009594","name":"University of P\u00e9cs","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100009594","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Cancer remains a significant public health challenge in Europe, with substantial regional disparities in incidence, mortality, and access to healthcare. This study analyses cancer patterns across Eastern, Northern, Southern, and Western Europe in 2022, highlighting key public health implications and gaps in prevention and treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Using data from GLOBOCAN 2022, this study assessed total new cancer cases, age-standardized incidence and mortality rates (ASRs) per 100,000, and cumulative cancer risk at age 75. The top three cancers by sex and region were also analysed to identify trends and disparities.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In 2022, Europe recorded 4,471,422 new cancer cases (ASR 280 per 100,000), with a cumulative risk of 27.9% by age 75. Males accounted for 2,359,303 cases (ASR 319.6, cumulative risk 31.9%), while females had 2,112,119 cases (ASR 253.4, cumulative risk 24.7%). Northern and Western Europe had the highest incidence rates, with Denmark leading at 374.7 per 100,000 (cumulative risk 34.9%), likely due to advanced screening and healthcare. Conversely, Eastern Europe had the highest mortality, with 1,091,871 deaths (ASR 135.3), reflecting late diagnoses and limited access of treatment. Hungary exhibited the highest mortality rate (ASR 143.7, cumulative risk 15.8%), followed by Poland (ASR 133.1). Prostate and breast cancers were the most common in males and females, respectively. Lung cancer, despite a lower incidence (ASR 24.7), had the highest mortality (ASR 17.7), while pancreatic cancer showed high fatality (ASR 6.3, mortality ASR 5.6). Thyroid cancer had a relatively high incidence (ASR 7.5) but low mortality (ASR 0.21).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Significant regional disparities in cancer burden underscore the need for targeted public health strategies. Expanding cancer screening programs, strengthening smoking cessation and HPV vaccination efforts, and improving healthcare accessibility particularly in Eastern Europe are critical to reducing mortality and enhancing early detection. Differences in mortality-to-incidence ratios also highlight the role of healthcare infrastructure and timely interventions. Future research should explore the socioeconomic and environmental determinants driving these disparities to inform evidence-based cancer control policies across Europe.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12885-025-13862-1","type":"journal-article","created":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T14:16:47Z","timestamp":1741789007000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":82,"title":["Cancer burden in Europe: a systematic analysis of the GLOBOCAN database (2022)"],"prefix":"10.1186","volume":"25","author":[{"given":"Mohammed","family":"Elmadani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter Onchuru","family":"Mokaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed A. A.","family":"Omer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evans Kasmai","family":"Kiptulon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Klara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mate","family":"Orsolya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,12]]},"reference":[{"issue":"10352","key":"13862_CR1","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/S0140-6736(22)01438-6","volume":"400","author":"KB Tran","year":"2022","unstructured":"Tran KB, Lang JJ, Compton K, Xu R, Acheson AR, Henrikson HJ, et al. The global burden of cancer attributable to risk factors, 2010\u201319: a systematic analysis for the global burden of disease study 2019. Lancet. 2022;400(10352):563\u201391. https:\/\/doi.org\/10.1016\/S0140-6736(22)01438-6.","journal-title":"Lancet"},{"issue":"3","key":"13862_CR2","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/S1470-2045(24)00089-5","volume":"25","author":"SF Shariat","year":"2024","unstructured":"Shariat SF. A pan-European total cancer prevalence canvas: a benchmark for advancing strategic interventions. Lancet Oncol. 2024;25(3):266\u20137. https:\/\/doi.org\/10.1016\/S1470-2045(24)00089-5.","journal-title":"Lancet Oncol"},{"issue":"sup2","key":"13862_CR3","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1080\/13696998.2024.2374684","volume":"27","author":"G Bencina","year":"2024","unstructured":"Bencina G, Sabale U, Morais E, Ovcinnikova O, Oliver E, Shoel H, et al. Burden and indirect cost of vaccine-preventable cancer mortality in Europe. J Med Econ. 2024;27(sup2):30\u201340. https:\/\/doi.org\/10.1080\/13696998.2024.2374684.","journal-title":"J Med Econ"},{"issue":"3","key":"13862_CR4","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2022","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J Clin. 2022;74(3):229\u201363. https:\/\/doi.org\/10.3322\/caac.21834.","journal-title":"Cancer J Clin"},{"key":"13862_CR5","unstructured":"WHO. Latest global cancer data: Cancer burden rises to 18.1 million new cases and 9.6 million cancer deaths in 2018: International Agency for Research on Cancer. 2018 [263:[Available from: https:\/\/www.iarc.who.int\/wp-content\/uploads\/2018\/09\/pr263_E.pdf"},{"issue":"2","key":"13862_CR6","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/S1470-2045(24)00002-0","volume":"25","author":"A Charalambous","year":"2024","unstructured":"Charalambous A, Price R, Jha P. Accelerating progress on EU cancer control. Lancet Oncol. 2024;25(2):158\u201360. https:\/\/doi.org\/10.1016\/S1470-2045(24)00002-0. https:\/\/doi.org\/https:\/\/.","journal-title":"Lancet Oncol"},{"issue":"3","key":"13862_CR7","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.jncc.2024.05.002","volume":"4","author":"L Li","year":"2024","unstructured":"Li L, Shan T, Zhang D, Ma F. Nowcasting and forecasting global aging and cancer burden: analysis of data from the GLOBOCAN and global burden of disease study. J Natl Cancer Cent. 2024;4(3):223\u201332. https:\/\/doi.org\/10.1016\/j.jncc.2024.05.002.","journal-title":"J Natl Cancer Cent"},{"key":"13862_CR8","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.ejca.2021.07.039","volume":"157","author":"T Dyba","year":"2021","unstructured":"Dyba T, Randi G, Bray F, Martos C, Giusti F, Nicholson N, et al. The European cancer burden in 2020: incidence and mortality estimates for 40 countries and 25 major cancers. Eur J Cancer. 2021;157:308\u201347. https:\/\/doi.org\/10.1016\/j.ejca.2021.07.039.","journal-title":"Eur J Cancer"},{"key":"13862_CR9","doi-asserted-by":"publisher","unstructured":"Ju W, Zheng R, Wang S, Zhang S, Zeng H, Chen R, et al. The occurrence of cancer in ageing populations at global and regional levels, 1990 to 2019. Age Ageing. 2023;52(9). https:\/\/doi.org\/10.1093\/ageing\/afad043.","DOI":"10.1093\/ageing\/afad043"},{"key":"13862_CR10","doi-asserted-by":"publisher","unstructured":"Fan Y, Jiang Y, Gong L, Wang Y, Su Z, Li X, et al. Epidemiological and demographic drivers of lung cancer mortality from 1990 to 2019: results from the global burden of disease study 2019. Front Public Health. 2023;11. https:\/\/doi.org\/10.3389\/fpubh.2023.1054200.","DOI":"10.3389\/fpubh.2023.1054200"},{"issue":"6","key":"13862_CR11","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1002\/jso.27459","volume":"128","author":"L Newman","year":"2023","unstructured":"Newman L. Oncologic anthropology: global variations in breast cancer risk, biology, and outcome. J Surg Oncol. 2023;128(6):959\u201366. https:\/\/doi.org\/10.1002\/jso.27459. https:\/\/doi.org\/https:\/\/doi.org\/.","journal-title":"J Surg Oncol"},{"issue":"16suppl","key":"13862_CR12","doi-asserted-by":"publisher","first-page":"10528","DOI":"10.1200\/JCO.2023.41.16_suppl.10528","volume":"41","author":"ET Sedeta","year":"2023","unstructured":"Sedeta ET, Jobre B, Avezbakiyev B. Breast cancer: global patterns of incidence, mortality, and trends. J Clin Oncol. 2023;41(16suppl):10528. https:\/\/doi.org\/10.1200\/JCO.2023.41.16_suppl.10528.","journal-title":"J Clin Oncol"},{"key":"13862_CR13","doi-asserted-by":"publisher","unstructured":"Yu S, Cai X, Wang X, Lin X, Cai S. Disease burden of breast cancer and risk factors in Europe 44 countries, 1990\u20132019: findings of the global burden of disease study 2019. Front Endocrinol. 2024;15. https:\/\/doi.org\/10.3389\/fendo.2024.1405204.","DOI":"10.3389\/fendo.2024.1405204"},{"key":"13862_CR14","unstructured":"OECD. Beating Cancer Inequalities in the EU2024."},{"issue":"6","key":"13862_CR15","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1097\/cco.0000000000000991","volume":"35","author":"O Amato","year":"2023","unstructured":"Amato O, Guarneri V, Girardi F. Epidemiology trends and progress in breast cancer survival: earlier diagnosis, new therapeutics. Curr Opin Oncol. 2023;35(6):612\u20139. https:\/\/doi.org\/10.1097\/cco.0000000000000991.","journal-title":"Curr Opin Oncol"},{"key":"13862_CR16","doi-asserted-by":"publisher","first-page":"9605439","DOI":"10.1155\/2022\/9605439","volume":"2022","author":"D Kashyap","year":"2022","unstructured":"Kashyap D, Pal D, Sharma R, Garg VK, Goel N, Koundal D, et al. Global increase in breast Cancer incidence: risk factors and preventive measures. Biomed Res Int. 2022;2022:9605439. https:\/\/doi.org\/10.1155\/2022\/9605439.","journal-title":"Biomed Res Int"},{"issue":"9","key":"13862_CR17","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/S2468-1253(21)00147-3","volume":"6","author":"RH Henderson","year":"2021","unstructured":"Henderson RH, French D, Maughan T, Adams R, Allemani C, Minicozzi P, et al. The economic burden of colorectal cancer across Europe: a population-based cost-of-illness study. Lancet Gastroenterol Hepatol. 2021;6(9):709\u201322. https:\/\/doi.org\/10.1016\/S2468-1253(21)00147-3.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"13862_CR18","doi-asserted-by":"publisher","first-page":"e077341","DOI":"10.1136\/bmj-2023-077341","volume":"385","author":"M Falcaro","year":"2024","unstructured":"Falcaro M, Soldan K, Ndlela B, Sasieni P. Effect of the HPV vaccination programme on incidence of cervical cancer and grade 3 cervical intraepithelial neoplasia by socioeconomic deprivation in England: population based observational study. BMJ. 2024;385:e077341. https:\/\/doi.org\/10.1136\/bmj-2023-077341.","journal-title":"BMJ"},{"key":"13862_CR19","doi-asserted-by":"publisher","first-page":"1252832","DOI":"10.3389\/fpsyg.2024.1252832","volume":"15","author":"G Ferraris","year":"2024","unstructured":"Ferraris G, Coppini V, Monzani D, Grasso R, Kirac I, Horgan D, et al. Addressing disparities in European cancer outcomes: a qualitative study protocol of the BEACON project. Front Psychol. 2024;15:1252832. https:\/\/doi.org\/10.3389\/fpsyg.2024.1252832.","journal-title":"Front Psychol"},{"issue":"8","key":"13862_CR20","doi-asserted-by":"publisher","first-page":"e3730","DOI":"10.1002\/jgm.3730","volume":"26","author":"I Ahmad","year":"2024","unstructured":"Ahmad I, Jasim SA, Sharma MK, Hjazi SRJ, Mohammed A. New paradigms to break barriers in early cancer detection for improved prognosis and treatment outcomes. J Gene Med. 2024;26(8):e3730. https:\/\/doi.org\/10.1002\/jgm.3730.","journal-title":"J Gene Med"},{"issue":"5","key":"13862_CR21","doi-asserted-by":"publisher","first-page":"e39634","DOI":"10.7759\/cureus.39634","volume":"15","author":"J Noor","year":"2023","unstructured":"Noor J, Chaudhry A, Batool S. Microfluidic technology, artificial intelligence, and biosensors as advanced technologies in Cancer screening: A review Article. Cureus. 2023;15(5):e39634. https:\/\/doi.org\/10.7759\/cureus.39634.","journal-title":"Cureus"},{"key":"13862_CR22","doi-asserted-by":"publisher","unstructured":"Annette L. Fighting the good fight: Europe\u2019s Beating Cancer Plan. Impact. 2023;2023(3):4\u20135 https:\/\/doi.org\/10.21820\/23987073.2023.3.4.","DOI":"10.21820\/23987073.2023.3.4."},{"issue":"3","key":"13862_CR23","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1097\/cej.0000000000000782","volume":"32","author":"G Corso","year":"2023","unstructured":"Corso G, Janssens JP, La Vecchia C. Cancer prevention: innovative strategies in the role of the European Cancer prevention organization. Eur J Cancer Prev. 2023;32(3):203\u20136. https:\/\/doi.org\/10.1097\/cej.0000000000000782.","journal-title":"Eur J Cancer Prev"},{"key":"13862_CR24","unstructured":"Ferlay JEM, Lam F, Laversanne M, Colombet M, Mery L, Pi\u00f1eros M, Znaor A, Soerjomataram I, Bray F. Global Cancer Observatory: Cancer Today: Lyon, France: International Agency for Research on Cancer; 2024 [cited 2025 15 February]. Available from: https:\/\/gco.iarc.who.int\/today\/en\/data-sources-methods"},{"key":"13862_CR25","doi-asserted-by":"publisher","unstructured":"Gehrmann J, Beyan O. Stud Health Technol Inf. 2024;316:9\u201313. https:\/\/doi.org\/10.3233\/shti240332. Data Quality in Medical Real-World Data - An Oncological Use Case.","DOI":"10.3233\/shti240332"},{"key":"13862_CR26","doi-asserted-by":"publisher","unstructured":"Martos C, Giusti F, Van Eycken L, Visser O, Editorial. Joining efforts to improve data quality and harmonization among European population-based cancer registries. Front Oncol. 2024;14. https:\/\/doi.org\/10.3389\/fonc.2024.1496574.","DOI":"10.3389\/fonc.2024.1496574"},{"key":"13862_CR27","doi-asserted-by":"publisher","unstructured":"Giusti F, Martos C, Carvalho RN, Zadnik V, Visser O, Bettio M, et al. Facing further challenges in cancer data quality and harmonisation. Front Oncol. 2024;14. https:\/\/doi.org\/10.3389\/fonc.2024.1438805.","DOI":"10.3389\/fonc.2024.1438805"},{"key":"13862_CR28","doi-asserted-by":"publisher","unstructured":"Stepien M, Rodriguez Rasero F, Ben E, Nicholl C. Monitoring inequalities in cancer prevention and care in Europe. Eur J Pub Health. 2023;33. https:\/\/doi.org\/10.1093\/eurpub\/ckad160.1679. Supplement_2.","DOI":"10.1093\/eurpub\/ckad160.1679"},{"key":"13862_CR29","doi-asserted-by":"publisher","unstructured":"Asensio M, Amaral E. Disparities in cancer outcomes: A comprehensive analysis of cancer incidence, mortality, and prevalence in Europe. GHES. 2024;2(2). https:\/\/doi.org\/10.36922\/ghes.3216.","DOI":"10.36922\/ghes.3216"},{"issue":"21","key":"13862_CR30","doi-asserted-by":"publisher","first-page":"2620","DOI":"10.1016\/j.scib.2023.09.041","volume":"68","author":"R Zheng","year":"2023","unstructured":"Zheng R, Wang S, Zhang S, Zeng H, Chen R, Sun K, et al. Global, regional, and National lifetime probabilities of developing cancer in 2020. Sci Bull (Beijing). 2023;68(21):2620\u20138. https:\/\/doi.org\/10.1016\/j.scib.2023.09.041.","journal-title":"Sci Bull (Beijing)"},{"key":"13862_CR31","unstructured":"McNutt L-A, Krug. Allison. cumulative incidence. Encyclopedia Britannica, 2016 [cited 2025 16 February]. Available from: https:\/\/www.britannica.com\/science\/cumulative-incidence."},{"issue":"1","key":"13862_CR32","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1186\/s12889-022-14412-1","volume":"22","author":"D Xiang","year":"2022","unstructured":"Xiang D, Hu S, Mai T, Zhang X, Zhang L, Wang S, et al. Worldwide cancer statistics of adults over 75 years old in 2019: a systematic analysis of the global burden of disease study 2019. BMC Public Health. 2022;22(1):1979. https:\/\/doi.org\/10.1186\/s12889-022-14412-1.","journal-title":"BMC Public Health"},{"issue":"11","key":"13862_CR33","doi-asserted-by":"publisher","first-page":"e2443198","DOI":"10.1001\/jamanetworkopen.2024.43198","volume":"7","author":"HM Bizuayehu","year":"2024","unstructured":"Bizuayehu HM, Ahmed KY, Kibret GD, Dadi AF, Belachew SA, Bagade T, et al. Global disparities of Cancer and its projected burden in 2050. JAMA Netw Open. 2024;7(11):e2443198\u2013e. https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.43198.","journal-title":"JAMA Netw Open"},{"issue":"3","key":"13862_CR34","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1038\/bjc.2011.250","volume":"105","author":"PD Sasieni","year":"2011","unstructured":"Sasieni PD, Shelton J, Ormiston-Smith N, Thomson CS, Silcocks PB. What is The lifetime risk of developing cancer? The effect of adjusting for multiple primaries. Br J Cancer. 2011;105(3):460\u20135. https:\/\/doi.org\/10.1038\/bjc.2011.250.","journal-title":"Br J Cancer"},{"issue":"3 Suppl 1","key":"13862_CR35","doi-asserted-by":"publisher","first-page":"S7","DOI":"10.1016\/j.amepre.2013.10.029","volume":"46","author":"MC White","year":"2014","unstructured":"White MC, Holman DM, Boehm JE, Peipins LA, Grossman M, Henley SJ. Age and cancer risk: a potentially modifiable relationship. Am J Prev Med. 2014;46(3 Suppl 1):S7\u201315. https:\/\/doi.org\/10.1016\/j.amepre.2013.10.029.","journal-title":"Am J Prev Med"},{"key":"13862_CR36","unstructured":"Nelson C. Some Older Adults Find an Age Cutoff For Colon Cancer Screenings \u2018Unacceptable\u2019\u2014Here\u2019s Why Doctors Say It Exists 2024 [cited 2025 16 February]. Available from: https:\/\/www.health.com\/colorectal-cancer-screening-age-cap-survey-8761413?utm_source=chatgpt.com"},{"key":"13862_CR37","doi-asserted-by":"publisher","DOI":"10.1787\/14fdc89a-en","volume-title":"Beating Cancer inequalities in the EU: spotlight on Cancer prevention and early detection, OECD health policy studies","author":"OECD","year":"2024","unstructured":"OECD. Beating Cancer inequalities in the EU: spotlight on Cancer prevention and early detection, OECD health policy studies. Paris: OECD Publishing; 2024."},{"key":"13862_CR38","unstructured":"Gerwin Winter EL. Tackling disparities in cancer care across Europe: how can we improve access for all patients in Europe? 2023 [cited 2025 17 February]. Available from: https:\/\/www.oncology-central.com\/tackling-disparities-in-cancer-care-across-europe-how-can-we-improve-access-for-all-patients-in-europe\/"},{"key":"13862_CR39","doi-asserted-by":"publisher","unstructured":"Ciuba A, Wnuk K, Nitsch-Osuch A, Kulpa M. Health care accessibility and breast Cancer mortality in Europe. Int J Environ Res Public Health. 2022;19(20). https:\/\/doi.org\/10.3390\/ijerph192013605.","DOI":"10.3390\/ijerph192013605"},{"issue":"June","key":"13862_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18332\/tid\/149477","volume":"20","author":"A Teshima","year":"2022","unstructured":"Teshima A, Laverty AA, Filippidis FT. Burden of current and past smoking across 28 European countries in 2017: A cross-sectional analysis. Tob Induc Dis. 2022;20(June):1\u201311. https:\/\/doi.org\/10.18332\/tid\/149477.","journal-title":"Tob Induc Dis"},{"issue":"1","key":"13862_CR41","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s12963-021-00247-2","volume":"19","author":"D Long","year":"2021","unstructured":"Long D, Mackenbach J, Martikainen P, Lundberg O, Br\u00f8nnum-Hansen H, Bopp M, et al. Smoking and inequalities in mortality in 11 European countries: a birth cohort analysis. Popul Health Metrics. 2021;19(1):3. https:\/\/doi.org\/10.1186\/s12963-021-00247-2.","journal-title":"Popul Health Metrics"},{"issue":"4","key":"13862_CR42","first-page":"327","volume":"4","author":"F Islami","year":"2015","unstructured":"Islami F, Torre LA, Jemal A. Global trends of lung cancer mortality and smoking prevalence. Translational Lung Cancer Res. 2015;4(4):327\u201338.","journal-title":"Translational Lung Cancer Res"},{"issue":"4","key":"13862_CR43","doi-asserted-by":"publisher","first-page":"327","DOI":"10.3978\/j.issn.2218-6751.2015.08.04","volume":"4","author":"F Islami","year":"2015","unstructured":"Islami F, Torre LA, Jemal A. Global trends of lung cancer mortality and smoking prevalence. Transl Lung Cancer Res. 2015;4(4):327\u201338. https:\/\/doi.org\/10.3978\/j.issn.2218-6751.2015.08.04.","journal-title":"Transl Lung Cancer Res"},{"key":"13862_CR44","doi-asserted-by":"publisher","first-page":"100085","DOI":"10.1016\/j.lanepe.2021.100085","volume":"4","author":"K Ten Haaf","year":"2021","unstructured":"Ten Haaf K. Confronting the burden of tobacco-related lung cancer in Europe in the next decades. Lancet Reg Health Eur. 2021;4:100085. https:\/\/doi.org\/10.1016\/j.lanepe.2021.100085.","journal-title":"Lancet Reg Health Eur"},{"key":"13862_CR45","unstructured":"organization Ec. Equal access to affordable and optimal cancer care, including the right to a second opinion. [cited 2025 17 February]. Available from: https:\/\/www.europeancancer.org\/content\/the-code-equal-access.html"},{"key":"13862_CR46","doi-asserted-by":"publisher","unstructured":"Borr\u00e0s JM, Fernandez E, Gonzalez JR, Negri E, Lucchini F, La Vecchia C, et al. Lung cancer mortality in European regions (1955\u20131997). Annals of Oncology. 2003;14(1):159\u2013\u200961 https:\/\/doi.org\/10.1093\/annonc\/mdg016.","DOI":"10.1093\/annonc\/mdg016."},{"key":"13862_CR47","unstructured":"WHO. Tobacco-related cancers and prevention 2020 [cited 2025 17 February]. Available from: https:\/\/cancerpreventioneurope.iarc.fr\/european-code-against-cancer\/tobacco-related-cancers-and-prevention\/"},{"issue":"16suppl","key":"13862_CR48","doi-asserted-by":"publisher","first-page":"e23276","DOI":"10.1200\/JCO.2024.42.16_suppl.e23276","volume":"42","author":"K Desai","year":"2024","unstructured":"Desai K, Baralo B, Kulkarni A, Keshava VE, Iqbal S, Ali H, et al. Cancer statistics: the united States vs. worldwide. J Clin Oncol. 2024;42(16suppl):e23276\u2013e. https:\/\/doi.org\/10.1200\/JCO.2024.42.16_suppl.e23276.","journal-title":"J Clin Oncol"},{"key":"13862_CR49","doi-asserted-by":"crossref","unstructured":"Haider M, Lange PH. Chapter 19 - Breast and Prostate Cancers: A Comparison of Two Endocrinologic Malignancies. In: Mydlo JH, Godec CJ, editors. Prostate Cancer (Second Edition). San Diego: Academic Press; 2016. pp. 157\u2013\u200965.","DOI":"10.1016\/B978-0-12-800077-9.00019-0"},{"issue":"1","key":"13862_CR50","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1186\/1471-2407-14-874","volume":"14","author":"G L\u00f3pez-Abente","year":"2014","unstructured":"L\u00f3pez-Abente G, Mispireta S, Poll\u00e1n M. Breast and prostate cancer: an analysis of common epidemiological features in mortality trends in Spain. BMC Cancer. 2014;14(1):874. https:\/\/doi.org\/10.1186\/1471-2407-14-874.","journal-title":"BMC Cancer"},{"issue":"12","key":"13862_CR51","doi-asserted-by":"publisher","first-page":"2954","DOI":"10.3390\/cancers14122954","volume":"14","author":"F De Silva","year":"2022","unstructured":"De Silva F, Alcorn J. A Tale of two cancers: A current concise overview of breast and prostate Cancer. Cancers. 2022;14(12):2954.","journal-title":"Cancers"},{"issue":"3","key":"13862_CR52","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer. J Clin. 2021;71(3):209\u201349. https:\/\/doi.org\/10.3322\/caac.21660.","journal-title":"J Clin"},{"issue":"2","key":"13862_CR53","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1007\/s10549-020-05561-1","volume":"180","author":"Z Chen","year":"2020","unstructured":"Chen Z, Xu L, Shi W, Zeng F, Zhuo R, Hao X, et al. Trends of female and male breast cancer incidence at the global, regional, and National levels, 1990\u20132017. Breast Cancer Res Treat. 2020;180(2):481\u201390. https:\/\/doi.org\/10.1007\/s10549-020-05561-1.","journal-title":"Breast Cancer Res Treat"},{"issue":"33","key":"13862_CR54","doi-asserted-by":"publisher","first-page":"2300655","DOI":"10.2807\/1560-7917.ES.2024.29.33.2300655","volume":"29","author":"J Beaut\u00e9","year":"2024","unstructured":"Beaut\u00e9 J, Innocenti F. Differences between males and females in infectious diseases notifications in the EU\/EEA, 2012 to 2021. Eurosurveillance. 2024;29(33):2300655. https:\/\/doi.org\/10.2807\/1560-7917.ES.2024.29.33.2300655.","journal-title":"Eurosurveillance"},{"key":"13862_CR55","doi-asserted-by":"publisher","unstructured":"Milutinovic S, Escarcega RO, Lopez-Mattei J, Petrovic M. Gender disparities and infective endocarditis burden in the united States and European union: a comparative analysis. Eur Heart J. 2024;45. https:\/\/doi.org\/10.1093\/eurheartj\/ehae666.2618. Supplement_1.","DOI":"10.1093\/eurheartj\/ehae666.2618"},{"issue":"16suppl","key":"13862_CR56","doi-asserted-by":"publisher","first-page":"e19052","DOI":"10.1200\/JCO.2023.41.16_suppl.e19052","volume":"41","author":"A Jain","year":"2023","unstructured":"Jain A, Jani C, Patel S, Raval M, Singh H. Age-standardized incidence, mortality rates, mortality-to-incidence ratios, and disability-adjusted life years for acute lymphoblastic leukemia in the European union 15\u2009+\u2009countries, Australia, and united States of America. J Clin Oncol. 2023;41(16suppl):e19052\u2013e. https:\/\/doi.org\/10.1200\/JCO.2023.41.16_suppl.e19052.","journal-title":"J Clin Oncol"},{"issue":"1","key":"13862_CR57","doi-asserted-by":"publisher","first-page":"e30","DOI":"10.1634\/theoncologist.2018-0093","volume":"24","author":"E Vrdoljak","year":"2018","unstructured":"Vrdoljak E, Bodoky G, Jassem J, Popescu R, Pirker R, \u010cufer T, et al. Expenditures on oncology drugs and Cancer Mortality-to\u2010Incidence ratio in central and Eastern Europe. Oncologist. 2018;24(1):e30\u20137. https:\/\/doi.org\/10.1634\/theoncologist.2018-0093.","journal-title":"Oncologist"},{"key":"13862_CR58","doi-asserted-by":"publisher","unstructured":"Trojanowski M, Radomyski P, Kycler W, Michalek IM. Decrease in the number of new cancer diagnoses during the first year of the COVID-19 pandemic\u2013 cohort study of 3.5 million individuals in Western Poland. Front Oncol. 2023;13. https:\/\/doi.org\/10.3389\/fonc.2023.1230289.","DOI":"10.3389\/fonc.2023.1230289"},{"key":"13862_CR59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejca.2022.01.007","volume":"165","author":"C Santucci","year":"2022","unstructured":"Santucci C, Patel L, Malvezzi M, Wojtyla C, La Vecchia C, Negri E, et al. Persisting cancer mortality gap between Western and Eastern Europe. Eur J Cancer. 2022;165:1\u201312. https:\/\/doi.org\/10.1016\/j.ejca.2022.01.007.","journal-title":"Eur J Cancer"},{"key":"13862_CR60","doi-asserted-by":"publisher","first-page":"1420178","DOI":"10.3389\/fonc.2024.1420178","volume":"14","author":"V Coppini","year":"2024","unstructured":"Coppini V, Ferraris G, Ferrari MV, Dah\u00f2 M, Kirac I, Renko I, et al. Patients\u2019 perspectives on cancer care disparities in central and Eastern European countries: experiencing taboos, misinformation and barriers in the healthcare system. Front Oncol. 2024;14:1420178. https:\/\/doi.org\/10.3389\/fonc.2024.1420178.","journal-title":"Front Oncol"},{"issue":"3","key":"13862_CR61","first-page":"175","volume":"66","author":"I Kenessey","year":"2022","unstructured":"Kenessey I, Nagy P, Polg\u00e1r C. [The Hungarian situation of cancer epidemiology in the second decade of the 21st century]. Magy Onkol. 2022;66(3):175\u201384.","journal-title":"Magy Onkol"},{"issue":"10","key":"13862_CR62","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1634\/theoncologist.2016-0137","volume":"21","author":"E Vrdoljak","year":"2016","unstructured":"Vrdoljak E, Bodoky G, Jassem J, Popescu RA, Mardiak J, Pirker R, et al. Cancer control in central and Eastern Europe: current situation and recommendations for improvement. Oncologist. 2016;21(10):1183\u201390. https:\/\/doi.org\/10.1634\/theoncologist.2016-0137.","journal-title":"Oncologist"},{"issue":"3","key":"13862_CR63","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363. https:\/\/doi.org\/10.3322\/caac.21834.","journal-title":"CA Cancer J Clin"},{"issue":"11","key":"13862_CR64","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1093\/jnci\/djq134","volume":"102","author":"S Lodi","year":"2010","unstructured":"Lodi S, Guiguet M, Costagliola D, Fisher M, de Luca A, Porter K. Kaposi sarcoma incidence and survival among HIV-infected homosexual men after HIV seroconversion. J Natl Cancer Inst. 2010;102(11):784\u201392. https:\/\/doi.org\/10.1093\/jnci\/djq134.","journal-title":"J Natl Cancer Inst"},{"issue":"5","key":"13862_CR65","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1111\/hiv.12584","volume":"19","author":"Z Liu","year":"2018","unstructured":"Liu Z, Fang Q, Zuo J, Minhas V, Wood C, Zhang T. The world-wide incidence of Kaposi\u2019s sarcoma in the HIV\/AIDS era. HIV Med. 2018;19(5):355\u201364. https:\/\/doi.org\/10.1111\/hiv.12584.","journal-title":"HIV Med"},{"key":"13862_CR66","unstructured":"UK. CR. Risks and causes of vaginal cancer 2022 [cited 2025 17 February]. Available from: https:\/\/www.cancerresearchuk.org\/about-cancer\/vaginal-cancer\/risk-causes?utm_source=chatgpt.com"},{"issue":"S10","key":"13862_CR67","doi-asserted-by":"publisher","first-page":"2873","DOI":"10.1002\/cncr.23757","volume":"113","author":"X Wu","year":"2008","unstructured":"Wu X, Matanoski G, Chen VW, Saraiya M, Coughlin SS, King JB, et al. Descriptive epidemiology of vaginal cancer incidence and survival by race, ethnicity, and age in the united States. Cancer. 2008;113(S10):2873\u201382. https:\/\/doi.org\/10.1002\/cncr.23757.","journal-title":"Cancer"},{"issue":"11","key":"13862_CR68","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1016\/s1470-2045(19)30456-5","volume":"20","author":"M Arnold","year":"2019","unstructured":"Arnold M, Rutherford MJ, Bardot A, Ferlay J, Andersson TM, Myklebust T, et al. Progress in cancer survival, mortality, and incidence in seven high-income countries 1995\u20132014 (ICBP SURVMARK-2): a population-based study. Lancet Oncol. 2019;20(11):1493\u2013505. https:\/\/doi.org\/10.1016\/s1470-2045(19)30456-5.","journal-title":"Lancet Oncol"},{"issue":"8","key":"13862_CR69","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/s1470-2045(20)30388-0","volume":"21","author":"C Maringe","year":"2020","unstructured":"Maringe C, Spicer J, Morris M, Purushotham A, Nolte E, Sullivan R, et al. The impact of the COVID-19 pandemic on cancer deaths due to delays in diagnosis in England, UK: a National, population-based, modelling study. Lancet Oncol. 2020;21(8):1023\u201334. https:\/\/doi.org\/10.1016\/s1470-2045(20)30388-0.","journal-title":"Lancet Oncol"},{"issue":"11","key":"13862_CR70","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1038\/s41571-020-0388-9","volume":"17","author":"N Pashayan","year":"2020","unstructured":"Pashayan N, Antoniou AC, Ivanus U, Esserman LJ, Easton DF, French D, et al. Personalized early detection and prevention of breast cancer: ENVISION consensus statement. Nat Rev Clin Oncol. 2020;17(11):687\u2013705. https:\/\/doi.org\/10.1038\/s41571-020-0388-9.","journal-title":"Nat Rev Clin Oncol"},{"issue":"6","key":"13862_CR71","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.3390\/cancers12061409","volume":"12","author":"R Cardoso","year":"2020","unstructured":"Cardoso R, Guo F, Heisser T, Hoffmeister M, Brenner H. Utilisation of colorectal Cancer screening tests in European countries by type of screening offer: results from the European health interview survey. Cancers. 2020;12(6):1409.","journal-title":"Cancers"},{"issue":"13","key":"13862_CR72","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1056\/NEJMoa0810084","volume":"360","author":"FH Schr\u00f6der","year":"2009","unstructured":"Schr\u00f6der FH, Hugosson J, Roobol MJ, Tammela TL, Ciatto S, Nelen V, et al. Screening and prostate-cancer mortality in a randomized European study. N Engl J Med. 2009;360(13):1320\u20138. https:\/\/doi.org\/10.1056\/NEJMoa0810084.","journal-title":"N Engl J Med"},{"issue":"1","key":"13862_CR73","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.eururo.2019.02.009","volume":"76","author":"J Hugosson","year":"2019","unstructured":"Hugosson J, Roobol MJ, M\u00e5nsson M, Tammela TLJ, Zappa M, Nelen V, et al. A 16-yr Follow-up of the European randomized study of screening for prostate Cancer. Eur Urol. 2019;76(1):43\u201351. https:\/\/doi.org\/10.1016\/j.eururo.2019.02.009.","journal-title":"Eur Urol"},{"issue":"2","key":"13862_CR74","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.eururo.2020.09.042","volume":"79","author":"N Mottet","year":"2021","unstructured":"Mottet N, van den Bergh RCN, Briers E, Van den Broeck T, Cumberbatch MG, De Santis M, et al. EAU-EANM-ESTRO-ESUR-SIOG guidelines on prostate Cancer-2020 update. Part 1: screening, diagnosis, and local treatment with curative intent. Eur Urol. 2021;79(2):243\u201362. https:\/\/doi.org\/10.1016\/j.eururo.2020.09.042.","journal-title":"Eur Urol"},{"key":"13862_CR75","doi-asserted-by":"publisher","unstructured":"Relander P, Rauhaniemi E, L\u00f6yttyniemi E, Salminen K, Carpelan A, Koffert J. First local results of the Finnish FIT-based colorectal cancer screening program - high yield, low complications. Scand J Gastroenterol. 2025;1\u20136. https:\/\/doi.org\/10.1080\/00365521.2025.2458062.","DOI":"10.1080\/00365521.2025.2458062"},{"key":"13862_CR76","doi-asserted-by":"publisher","first-page":"100920","DOI":"10.1016\/j.lanepe.2024.100920","volume":"41","author":"I Ola","year":"2024","unstructured":"Ola I, Cardoso R, Hoffmeister M, Brenner H. Utilization of colorectal cancer screening tests across European countries: a cross-sectional analysis of the European health interview survey 2018\u20132020. Lancet Reg Health Eur. 2024;41:100920. https:\/\/doi.org\/10.1016\/j.lanepe.2024.100920.","journal-title":"Lancet Reg Health Eur"},{"issue":"3","key":"13862_CR77","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.annonc.2023.12.003","volume":"35","author":"C Santucci","year":"2024","unstructured":"Santucci C, Mignozzi S, Malvezzi M, Boffetta P, Collatuzzo G, Levi F, et al. European cancer mortality predictions for the year 2024 with focus on colorectal cancer. Ann Oncol. 2024;35(3):308\u201316. https:\/\/doi.org\/10.1016\/j.annonc.2023.12.003.","journal-title":"Ann Oncol"},{"issue":"1","key":"13862_CR78","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1186\/s12885-022-10243-w","volume":"22","author":"M Roginski","year":"2022","unstructured":"Roginski M, Sifaki-Pistolla D, Stomby A, Velivasaki G, Faresj\u00f6 T, Lionis C, et al. Paradoxes of breast cancer incidence and mortality in two corners of Europe. BMC Cancer. 2022;22(1):1123. https:\/\/doi.org\/10.1186\/s12885-022-10243-w.","journal-title":"BMC Cancer"},{"key":"13862_CR79","doi-asserted-by":"publisher","first-page":"102803","DOI":"10.1016\/j.jhealeco.2023.102803","volume":"92","author":"S Guthmuller","year":"2023","unstructured":"Guthmuller S, Carrieri V, W\u00fcbker A. Effects of organized screening programs on breast cancer screening, incidence, and mortality in Europe. J Health Econ. 2023;92:102803. https:\/\/doi.org\/10.1016\/j.jhealeco.2023.102803.","journal-title":"J Health Econ"},{"key":"13862_CR80","unstructured":"Foundation FB. Successful prevention 2024 [cited 2025 17 February]. Available from: https:\/\/www.burda.com\/en\/company\/responsibility\/foundations\/felix-burda-foundation\/"},{"issue":"1","key":"13862_CR81","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1186\/s12916-024-03632-4","volume":"22","author":"MJ Stein","year":"2024","unstructured":"Stein MJ, Baurecht H, Bohmann P, Fervers B, Fontvieille E, Freisling H, et al. Diurnal timing of physical activity and risk of colorectal cancer in the UK biobank. BMC Med. 2024;22(1):399. https:\/\/doi.org\/10.1186\/s12916-024-03632-4.","journal-title":"BMC Med"},{"key":"13862_CR82","unstructured":"Guardian T. Early morning and evening activity could \u2018reduce bowel cancer risk by 11% 2024 [cited 2025 17 February]. Available from: https:\/\/www.theguardian.com\/society\/2024\/nov\/06\/early-morning-and-evening-activity-could-reduce-bowel-cancer-risk"},{"key":"13862_CR83","doi-asserted-by":"publisher","unstructured":"Villain P, Gonzalez P, Almonte M, Franceschi S, Dillner J, Anttila A, et al. European code against Cancer 4th edition: infections and Cancer. Cancer Epidemiol. 2015;39. https:\/\/doi.org\/10.1016\/j.canep.2015.10.006. S120-S38.","DOI":"10.1016\/j.canep.2015.10.006"},{"issue":"11","key":"13862_CR84","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.3390\/vaccines12111293","volume":"12","author":"F Branda","year":"2024","unstructured":"Branda F, Pavia G, Ciccozzi A, Quirino A, Marascio N, Gigliotti S, et al. Human papillomavirus (HPV) vaccination: progress, challenges, and future directions in global immunization strategies. Vaccines. 2024;12(11):1293.","journal-title":"Vaccines"},{"issue":"29","key":"13862_CR85","doi-asserted-by":"publisher","first-page":"3793","DOI":"10.3748\/wjg.v28.i29.3793","volume":"28","author":"B Gnyawali","year":"2022","unstructured":"Gnyawali B, Pusateri A, Nickerson A, Jalil S, Mumtaz K. Epidemiologic and socioeconomic factors impacting hepatitis B virus and related hepatocellular carcinoma. World J Gastroenterol. 2022;28(29):3793\u2013802. https:\/\/doi.org\/10.3748\/wjg.v28.i29.3793.","journal-title":"World J Gastroenterol"},{"key":"13862_CR86","doi-asserted-by":"publisher","unstructured":"Shen C, Jiang X, Li M, Luo Y. Hepatitis virus and hepatocellular carcinoma: recent advances. Cancers (Basel). 2023;15(2). https:\/\/doi.org\/10.3390\/cancers15020533.","DOI":"10.3390\/cancers15020533"},{"issue":"1","key":"13862_CR87","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s41256-017-0038-7","volume":"2","author":"S Barsanti","year":"2017","unstructured":"Barsanti S, Salmi L-R, Bourgueil Y, Daponte A, Pinzal E, M\u00e9nival S. Strategies and governance to reduce health inequalities: evidences from a cross-European survey. Global Health Res Policy. 2017;2(1):18. https:\/\/doi.org\/10.1186\/s41256-017-0038-7.","journal-title":"Global Health Res Policy"},{"issue":"2","key":"13862_CR88","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.soncn.2017.02.002","volume":"33","author":"JT Loud","year":"2017","unstructured":"Loud JT, Murphy J. Cancer screening and early detection in the 21(st) century. Semin Oncol Nurs. 2017;33(2):121\u20138. https:\/\/doi.org\/10.1016\/j.soncn.2017.02.002.","journal-title":"Semin Oncol Nurs"},{"key":"13862_CR89","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1200\/edbk_238965","volume":"39","author":"AM Lopez","year":"2019","unstructured":"Lopez AM, Hudson L, Vanderford NL, Vanderpool R, Griggs J, Schonberg M. Epidemiology and implementation of Cancer prevention in disparate populations and settings. Am Soc Clin Oncol Educ Book. 2019;39:50\u201360. https:\/\/doi.org\/10.1200\/edbk_238965.","journal-title":"Am Soc Clin Oncol Educ Book"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-13862-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-025-13862-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-13862-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T01:56:35Z","timestamp":1741830995000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-025-13862-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,12]]},"references-count":89,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["13862"],"URL":"https:\/\/doi.org\/10.1186\/s12885-025-13862-1","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,12]]},"assertion":[{"value":"11 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"447"}}